Dosidal · Switzerland

Ryaltris, Nasenspray, Suspension

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69672 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69672
atc: R01AD59
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2025-06-23
term: zugelassen
valid_until: 2030-06-22
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: R01AD59
authorisation_number: 69672
form: NASSS
holder: NOBEL Pharma Schweiz AG
holder_partner_nr: 1102452
it_number: 12.02.3.
name: Ryaltris, Nasenspray, Suspension
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
AwmyfvoEaOtz5dx8dNa1Q9DWmX1EfwDDqMwBTbrRQi5d21jJF6Ydy9Uvr4fftkPK6ETPbwBSDovo9lsQQSocag
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:69672 · Related records in other markets · Dosidal